GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 74 filers reported holding GAMIDA CELL LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $750,501 | -46.6% | 728,642 | +0.1% | 0.00% | -50.0% |
| Q2 2023 | $1,404,661 | +240013.0% | 728,083 | +0.7% | 0.00% | +100.0% |
| Q1 2023 | $585 | -37.1% | 722,792 | +0.3% | 0.00% | -33.3% |
| Q4 2022 | $930 | -99.9% | 720,913 | +0.7% | 0.00% | -40.0% |
| Q3 2022 | $1,138,000 | -7.9% | 715,795 | +2.6% | 0.01% | 0.0% |
| Q2 2022 | $1,235,000 | -52.1% | 697,534 | +12.3% | 0.01% | -50.0% |
| Q1 2022 | $2,579,000 | +77.0% | 621,334 | +8.3% | 0.01% | +66.7% |
| Q4 2021 | $1,457,000 | -20.0% | 573,747 | +23.5% | 0.01% | -40.0% |
| Q3 2021 | $1,821,000 | -21.3% | 464,447 | +28.7% | 0.01% | -28.6% |
| Q2 2021 | $2,313,000 | +43.0% | 360,781 | +80.4% | 0.01% | +27.3% |
| Q1 2021 | $1,618,000 | +248.7% | 200,000 | +78.9% | 0.01% | +175.0% |
| Q3 2020 | $464,000 | – | 111,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
| Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
| Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
| Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
| FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
| Platform Technology Partners | 45,375 | $291,000 | 0.12% |
| PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
| Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |